Professor Jonathan Blackburn, chief scientific officer

Sengenics seeks strategic partners to advance autoantibody-based diagnostics and therapeutics

  • Leveraging its core technology, Sengenics has created Symphoni, the largest database of human autoantibody profiles across multiple ethnicities